Prevalence of extraintestinal manifestations in inflammatory bowel disease : a systematic review and meta-analysis
Author
Kilic, YakupKamal, Shahed
Jaffar, Farah
Sriranganathan, Danujan
Quraishi, Mohammed Nabil
Segal, Jonathan P.
Publication date
2023-04-12Subject
Gastroenterology
Metadata
Show full item recordAbstract
Background: Inflammatory bowel disease (IBD) is a multisystem disease impacting various body systems including musculoskeletal, ocular, skin, hepatobiliary, pulmonary, cardiac, and haematological systems. The extraintestinal manifestations of IBD are frequent, common in both ulcerative colitis (UC) and Crohn's disease (CD), and impact the morbidity and mortality of patients. Methods: The Embase, Embase classic, and PubMed databases were searched between January 1979 and December 2021. A random effects model was performed to find the pooled prevalence of joint, ocular, and skin extraintestinal manifestations of UC and CD. Results: Fifty-two studies were included that reported on 352 454 patients. The prevalence of at least 1 joint, ocular, or skin extraintestinal manifestation in all IBD, UC, and CD was 24%, 27%, and 35% respectively. The prevalence between UC and CD were similar for pyoderma gangrenosum and axial joint manifestations. Ocular manifestations were found to be more common in CD than in UC. Peripheral joint manifestations and erythema nodosum were found to be more common in CD than UC. Discussion: To our knowledge, this is the first meta-analysis that reports on the prevalence of at least 1 joint, ocular, or skin extraintestinal manifestation in IBD. Our results are largely consistent with figures and statements quoted in the literature. However, our findings are based on significantly larger cohort sizes. Thus, our results have the potential to better power studies and more accurately counsel patients.Citation
Kilic Y, Kamal S, Jaffar F, Sriranganathan D, Quraishi MN, Segal JP. Prevalence of Extraintestinal Manifestations in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. Inflamm Bowel Dis. 2024 Feb 1;30(2):230-239. doi: 10.1093/ibd/izad061.Type
ArticleAdditional Links
https://academic.oup.com/ibdjournal/advance-article-abstract/doi/10.1093/ibd/izad061/7115910PMID
37042969Journal
Inflammatory Bowel DiseasesPublisher
Oxford University Pressae974a485f413a2113503eed53cd6c53
10.1093/ibd/izad061